However, in our previous study we found that the serum levels of HCV RNA and ALT and HCV genotype were long-term predictors for hepatocellular carcinoma.[20] It was expected that the AUROC of the 10- and 15- year predicted risk for hepatocellular carcinoma should be improved in the validation cohort. The gene discussed is GPT; the disease is hepatocellular carcinoma.